Want the news summarized?
Subscribe to The Morning Report.

Deals and Data, Tim Ingersoll’s monthly waltz through the world of San Diego biotech, is making its rounds. Among the highlights in this month’s column is news from Amylin Pharmaceuticals and Arena Pharmaceuticals, two companies we wrote about Monday.

The Biocom spokesman also offers lots of other tidbits on everything from stock offerings to plant openings to drug successes and failures.

DAVID WASHBURN

Click here for more from The Venture

Leave a comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.